BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. Autoimmune liver serology: Current diagnostic and clinical challenges. World J Gastroenterol 2008; 14(21): 3374-3387 [PMID: 18528935 DOI: 10.3748/wjg.14.3374]
URL: https://www.wjgnet.com/1007-9327/full/v14/i21/3374.htm
(0) (0) (12358) (171)
Number Citing Articles
1
Dimitrios P. Bogdanos, Bin Gao, M. Eric Gershwin. Comprehensive Physiology. 2013;  doi: 10.1002/cphy.c120011
2
M Deutsch, C S Graffeo, R Rokosh, M Pansari, A Ochi, E M Levie, E Van Heerden, D M Tippens, S Greco, R Barilla, L Tomkötter, C P Zambirinis, N Avanzi, R Gulati, H L Pachter, A Torres-Hernandez, A Eisenthal, D Daley, G Miller. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. Cell Death & Disease 2015; 6(5) doi: 10.1038/cddis.2015.126
3
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Contemporary issues and future directions in autoimmune hepatitis. Expert Review of Gastroenterology & Hepatology 2016; 10(10) doi: 10.1080/17474124.2016.1193004
4
Lin Ma, Ming Li, Ting Zhang, Jia‐Qi Xu, Xue‐Bin Cao, Shan‐Shan Wu, Li‐Ying Sun. Incidence of de novo autoimmune hepatitis in children and adolescents with increased autoantibodies after liver transplantation: a meta‐analysis . Transplant International 2021; 34(3) doi: 10.1111/tri.13801
5
Albert J. Czaja. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5 doi: 10.1007/978-1-4419-7107-4_41
6
Lin Wu, Guang Song. Liver Proteomics. Methods in Molecular Biology 2012; 909 doi: 10.1007/978-1-61779-959-4_15
7
Jiang-Shan Lian, Wei Liu, Shao-Rui Hao, De-Ying Chen, Yin-Yin Wang, Jian-Le Yang, Hong-Yu Jia, Jian-Rong Huang. A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis. Hepatobiliary & Pancreatic Diseases International 2015; 14(4) doi: 10.1016/S1499-3872(15)60393-9
8
Takashi Himoto, Mikio Nishioka. Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Autoimmunity Highlights 2013; 4(2) doi: 10.1007/s13317-013-0046-7
9
Daniel S. Smyk, Eirini I. Rigopoulou, Mohammad Darkhabani, Pietro Invernizzi, Dimitrios P. Bogdanos. Infection and Autoimmunity. 2024;  doi: 10.1016/B978-0-323-99130-8.00025-8
10
Carmen M. Stanca, Costica Aloman, Maria Isabel Fiel, Kaiser Raja, Oguz Uskudar, Sander Florman, Thomas D. Schiano. The dynamic and clinical significance of autoantibodies and immunoglobulins in liver transplant recipients. Clinical Transplantation 2016; 30(3) doi: 10.1111/ctr.12682
11
Eirini I. Rigopoulou, Daniel S. Smyk, Claire E. Matthews, Charalambos Billinis, Andrew K. Burroughs, Marco Lenzi, Dimitrios P. Bogdanos. Epstein-Barr Virus as a Trigger of Autoimmune Liver Diseases. Advances in Virology 2012; 2012 doi: 10.1155/2012/987471
12
Hind I. Fallatah, Hisham O. Akbar. Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview. Autoimmune Diseases 2012; 2012 doi: 10.1155/2012/312817
13
Lydia A. Mercado, Fernando Gil-Lopez, Razvan M. Chirila, Denise M. Harnois. Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview. Diagnostics 2024; 14(4) doi: 10.3390/diagnostics14040382
14
Shima Mimura, Asahiro Morishita, Kyoko Oura, Rie Yano, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Miwa Tatsuta, Takashi Himoto, Hideki Kobara. Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets. Journal of Clinical Medicine 2025; 14(23) doi: 10.3390/jcm14238503
15
Gideon M. Hirschfield. Diagnosis of primary biliary cirrhosis. Best Practice & Research Clinical Gastroenterology 2011; 25(6) doi: 10.1016/j.bpg.2011.10.005
16
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Autoantibodies. 2014;  doi: 10.1016/B978-0-444-56378-1.00053-8
17
M.G. Mytilinaiou, D.P. Bogdanos. Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis. Digestive and Liver Disease 2009; 41(12) doi: 10.1016/j.dld.2009.05.005
18
E. Tinazzi, G. Patuzzo, C. Lunardi. Sjogren's Syndrome. 2016;  doi: 10.1016/B978-0-12-803604-4.00009-5
19
Houssem Hassen, Wafa Dahmani, Ghassen Bedoui, Safia Sakly, Emna Souilem, Yosr Ghdiri, Hanene Jaziri, Aida ben Slema, Ahlem Brahem, Nour Elleuch, Mehdi Ksiaa. Triple autoimmune overlap syndrome of the liver: a rare case of concomitant PBC, PSC, and AIH. Future Science OA 2025; 11(1) doi: 10.1080/20565623.2025.2601633
20
Kawa Amin, Aram H Rasool, Ali Hattem, Taha AM Al-Karboly, Taher E Taher, Jonas Bystrom. Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease. World Journal of Gastroenterology 2017; 23(8): 1345-1352 doi: 10.3748/wjg.v23.i8.1345
21
Heye Lv, Ao Deng, Yijun Chen, Zhenzhen Su. Clinical Performance of the Line Immunoassay and Digital Liquid Chip Method for Detecting Autoimmune Liver Disease Autoantibodies. Archives of Pathology & Laboratory Medicine 2025; 149(3) doi: 10.5858/arpa.2024-0057-OA
22
Hind I. Fallatah, Hisham O. Akbar. Elevated serum immunoglobulin G levels in patients with chronic liver disease in comparison to patients with autoimmune hepatitis. Libyan Journal of Medicine 2010; 5(1) doi: 10.3402/ljm.v5i0.4857
23
R. Liberal, G. Mieli-Vergani, D. Vergani. Autoimmune hepatitis: From mechanisms to therapy. Revista Clínica Española 2016; 216(7) doi: 10.1016/j.rce.2016.04.003
24
Zhen-Hua Ma, Xiao-Mei Wang, Rui-Hong Wu, Da-Lin Hao, Li-Chao Sun, Pan Li, Jun-Qi Niu. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis. World Journal of Gastroenterology 2022; 28(39): 5764-5783 doi: 10.3748/wjg.v28.i39.5764
25
Diego Vergani, Ian R. Mackay, Giorgina Mieli-Vergani. The Autoimmune Diseases. 2020;  doi: 10.1016/B978-0-12-812102-3.00057-9
26
Ian R. Mackay. Autoimmune hepatitis: What must be said. Experimental and Molecular Pathology 2012; 93(3) doi: 10.1016/j.yexmp.2012.11.001
27
Pietro Invernizzi, Luigi Muratori. Autoantibodies. 2014;  doi: 10.1016/B978-0-444-56378-1.00026-5
28
Ikuko Haruta, Ken Kikuchi, Minoru Nakamura, Katsuhiko Hirota, Hidehito Kato, Hiroshi Miyakawa, Noriyuki Shibata, Yoichiro Miyake, Etsuko Hashimoto, Keiko Shiratori, Junji Yagi. Involvement of Commensal Bacteria may Lead to Dysregulated Inflammatory and Autoimmune Responses in a Mouse Model for Chronic Nonsuppurative Destructive Cholangitis. Journal of Clinical Immunology 2012; 32(5) doi: 10.1007/s10875-012-9712-1
29
Christopher Khayeka-Wandabwa, Xiaoshuang Ma, Xiaolin Cao, Venkatrao Nunna, Janak L. Pathak, Rita Bernhardt, Pengcheng Cai, Matthias Bureik. Plasma membrane localization of CYP4Z1 and CYP19A1 and the detection of anti-CYP19A1 autoantibodies in humans. International Immunopharmacology 2019; 73 doi: 10.1016/j.intimp.2019.05.003
30
Aliya Gulamhusein, Patrick McKiernan. Autoimmune Liver Disease. 2020;  doi: 10.1002/9781119532637.ch6
31
Tryptophan-kynurenine profile in pediatric autoimmune hepatitis. Immunologic Research 2019; 67(1) doi: 10.1007/s12026-019-9068-1
32
Pierre Youinou. Conference Scene: Highlights of the 7th Autoimmunity Congress. Immunotherapy 2010; 2(5) doi: 10.2217/imt.10.49
33
Camilla Stephens, Agustin Castiella, Eva M. Gomez-Moreno, Pedro Otazua, Miguel-Ángel López-Nevot, Eva Zapata, Aida Ortega-Alonso, Francisco Ruiz-Cabello, Inmaculada Medina-Cáliz, Mercedes Robles-Díaz, German Soriano, Eva Roman, Hacibe Hallal, José M. Moreno-Planas, Martin Prieto, Raúl J. Andrade, M. Isabel Lucena. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis. Pharmacogenetics and Genomics 2016; 26(9) doi: 10.1097/FPC.0000000000000230
34
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Serology in autoimmune hepatitis: A clinical-practice approach. European Journal of Internal Medicine 2018; 48 doi: 10.1016/j.ejim.2017.10.006
35
Gert Hausdorf, Dirk Roggenbuck, Eugen Feist, Thomas Büttner, Peter R. Jungblut, Karsten Conrad, Christoph Berg, Reinhild Klein. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA—Revival of a disease-activity marker in autoimmune hepatitis. Clinica Chimica Acta 2009; 408(1-2) doi: 10.1016/j.cca.2009.06.035
36
Daniel Smyk, Eirini I. Rigopoulou, Nicola Bizzaro, Dimitrios P. Bogdanos. Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis. Autoimmunity Highlights 2013; 4(1) doi: 10.1007/s13317-011-0027-7
37
Danilo Villalta, Maria G. Mytilinaiou, Martina Elsner, Christian Hentschel, Juliane Cuccato, Valentina Somma, Peter Schierack, Dirk Roggenbuck, Dimitrios P. Bogdanos. Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases. Clinica Chimica Acta 2015; 450 doi: 10.1016/j.cca.2015.07.021
38
Venkatrao Nunna, Nasir Jalal, Matthias Bureik. Anti-CYP4Z1 autoantibodies detected in breast cancer patients. Cellular & Molecular Immunology 2017; 14(6) doi: 10.1038/cmi.2017.21
39
Lukas Burghart. Autoimmune Lebererkrankungen. rheuma plus 2023; 22(4) doi: 10.1007/s12688-023-00628-5
40
Maria C. SORRENTINO, Teresa CARBONE, Luigi CINQUANTA, Maria G. ALESSIO, Maria INFANTINO, Gaia DELEONARDI, Maria T. TREVISAN, Brunetta PORCELLI, Lucia TERZUOLI, Stefan PLATZGUMMER, Ignazio BRUSCA, Antonio ANTICO, Marilina TAMPOIA, Giampaola PESCE, Danilo VILLALTA, Nicola BIZZARO. Linee guida SIPMeL per la determinazione degli autoanticorpi nella diagnosi delle malattie autoimmuni del fegato. La Rivista Italiana della Medicina di Laboratorio 2024; 20(1) doi: 10.23736/S1825-859X.24.00226-3
41
F Machado Ribeiro, T Goldenberg. Mycobacteria and autoimmunity. Lupus 2015; 24(4-5) doi: 10.1177/0961203314559634
42
Daniel Smyk, Evangelos Cholongitas, Stephen Kriese, Eirini I. Rigopoulou, Dimitrios P. Bogdanos. Primary Biliary Cirrhosis: Family Stories. Autoimmune Diseases 2011; 2011 doi: 10.4061/2011/189585
43
Saveria Mazzara, Antonia Sinisi, Angela Cardaci, Riccardo Lorenzo Rossi, Luigi Muratori, Sergio Abrignani, Mauro Bombaci, Anna Carla Goldberg. Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis. PLOS ONE 2015; 10(9) doi: 10.1371/journal.pone.0137927
44
Maria Concetta Sorrentino, Danilo Villalta, Teresa Carbone, Maria Grazia Alessio, Maria Infantino, Luigi Cinquanta, Gaia Deleonardi, Stefan Platzgummer, Maria Teresa Trevisan, Giampaola Pesce, Brunetta Porcelli, Marilina Tampoia, Antonio Antico, Ignazio Brusca, Nicola Bizzaro. Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) guidelines on the use of autoantibody tests in the diagnosis of autoimmune liver diseases. Autoimmunity Reviews 2026; 25(7) doi: 10.1016/j.autrev.2026.104093
45
G.M. Hirschfield, E.J. Heathcote. Zakim and Boyer's Hepatology. 2012;  doi: 10.1016/B978-1-4377-0881-3.00043-7
46
Carolina Duarte-Rey, Dimitrios Bogdanos, Chen-Yen Yang, Krista Roberts, Patrick S.C. Leung, Juan-Manuel Anaya, Howard J. Worman, M. Eric Gershwin. Primary biliary cirrhosis and the nuclear pore complex. Autoimmunity Reviews 2012; 11(12) doi: 10.1016/j.autrev.2012.03.005
47
Catherine Johanet, Elvire Beleoken, Eric Ballot. Autoantibodies in autoimmune hepatitis: Antinuclear antibodies (ANA). Clinics and Research in Hepatology and Gastroenterology 2012; 36(4) doi: 10.1016/j.clinre.2012.02.005
48
Daniel S. Smyk, Eirini I. Rigopoulou, Pietro Invernizzi, Dimitrios P. Bogdanos. Infection and Autoimmunity. 2015;  doi: 10.1016/B978-0-444-63269-2.00075-1
49
Yannick Chantran, Éric Ballot, Catherine Johanet. Autoantibodies in primary biliary cirrhosis: Antimitochondrial autoantibodies. Clinics and Research in Hepatology and Gastroenterology 2013; 37(4) doi: 10.1016/j.clinre.2013.05.002
50
Daniel S. Smyk, Eirini I. Rigopoulou, Dimitrios P. Bogdanos. Potential Roles for Infectious Agents in the Pathophysiology of Primary Biliary Cirrhosis: What’s New?. Current Infectious Disease Reports 2013; 15(1) doi: 10.1007/s11908-012-0304-2
51
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Clinical significance of autoantibodies in autoimmune hepatitis. Journal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.08.001
52
Asli Gamze Sener. Autoantibodies in autoimmune liver diseases. APMIS 2015; 123(11) doi: 10.1111/apm.12442
53
Jochen Mattner. Natural killer T (NKT) cells in autoimmune hepatitis. Current Opinion in Immunology 2013; 25(6) doi: 10.1016/j.coi.2013.09.008
54
Daniel S. Smyk, Maria G. Mytilinaiou, Piotr Milkiewicz, Eirini I. Rigopoulou, Pietro Invernizzi, Dimitrios P. Bogdanos. Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22. Autoimmunity Highlights 2012; 3(1) doi: 10.1007/s13317-011-0023-y
55
Michael P. Manns, Ansgar W. Lohse, Diego Vergani. Autoimmune hepatitis – Update 2015. Journal of Hepatology 2015; 62(1) doi: 10.1016/j.jhep.2015.03.005
56
Christian Mayer, Beate Preuss, Julia Grottenthaler, Christoph Berg, Reinhild Klein. Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01151
57
E. Ballot, D. Khélifi-Touhani, A. Chhing. Autoanticorps en hépatologie. EMC - Hépatologie 2026; 41(1) doi: 10.1016/S1155-1976(25)49460-1
58
Ilaria Bianchi, Ana Lleo, Francesca Bernuzzi, Lisa Caliari, Dan S. Smyk, Pietro Invernizzi. The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics. Autoimmunity Highlights 2012; 3(3) doi: 10.1007/s13317-012-0043-2
59
Maria IS Achenza, Francesca Meda, Enrico Brunetta, Carlo Selmi. Serum autoantibodies for the diagnosis and management of autoimmune liver diseases. Expert Review of Gastroenterology & Hepatology 2012; 6(6) doi: 10.1586/egh.12.58
60
Aleksey Sergeevich Dorofeev, E. N. Aleksandrova, A. A. Novikov, K. G. Saliev, Yu. G. Sandler, E. V. Vinnitskaya. Diagnostic value of screening methods for the determination of antinuclear antibodies using indirect immunofluorescence on HEp-2 cells and enzyme immunoassay in autoimmune liver diseases. Russian Clinical Laboratory Diagnostics 2022; 67(11) doi: 10.51620/0869-2084-2022-67-11-652-657
61
C. M. Gambino, A. Aiello, G. Accardi, C. Caruso, G. Candore. Autoimmune diseases and 8.1 ancestral haplotype: An update. HLA 2018; 92(3) doi: 10.1111/tan.13305
62
Cornelia Dähnrich, Albert Pares, Llorenç Caballeria, Anke Rosemann, Wolfgang Schlumberger, Christian Probst, Maria Mytilinaiou, Dimitrios Bogdanos, Diego Vergani, Winfried Stöcker, Lars Komorowski. New ELISA for Detecting Primary Biliary Cirrhosis–Specific Antimitochondrial Antibodies. Clinical Chemistry 2009; 55(5) doi: 10.1373/clinchem.2008.118299
63
Jan Willem Cohen Tervaert, Bart van Hoek, Ger Koek. Antineutrophil Cytoplasmic Antibodies in Small-Duct Primary Sclerosing Cholangitis. Gastroenterology 2009; 136(1) doi: 10.1053/j.gastro.2008.11.033
64
Dimitrios P. Bogdanos, Daniel S. Smyk, Pietro Invernizzi, Eirini I. Rigopoulou, Miri Blank, Shideh Pouria, Yehuda Shoenfeld. Infectome: A platform to trace infectious triggers of autoimmunity. Autoimmunity Reviews 2013; 12(7) doi: 10.1016/j.autrev.2012.12.005
65
Gideon M. Hirschfield, M. Eric Gershwin. The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis. Annual Review of Pathology: Mechanisms of Disease 2013; 8(1) doi: 10.1146/annurev-pathol-020712-164014
66
Savino Sciascia, Nicola Bizzaro, Pier Luigi Meroni, Bogdanos Dimitrios, Maria Orietta Borghi, Xavier Bossuyt, Claudia Grossi, Dávid Tornai, Maria Papp, Yehuda Shoenfeld, Daniele Ielo, Marvin J. Fritzler. Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value. Autoimmunity Reviews 2023; 22(7) doi: 10.1016/j.autrev.2023.103356
67
Daniel S. Smyk, Dimitrios P. Bogdanos, Stephen Kriese, Charalambos Billinis, Andrew K. Burroughs, Eirini I. Rigopoulou. Urinary tract infection as a risk factor for autoimmune liver disease: From bench to bedside. Clinics and Research in Hepatology and Gastroenterology 2012; 36(2) doi: 10.1016/j.clinre.2011.07.013
68
Catherine Johanet, Eric Ballot. Autoantibodies in autoimmune hepatitis: Anti-liver kidney microsome type 1 (anti-LKM1) and anti-liver cytosol type 1 (anti-LC1) antibodies. Clinics and Research in Hepatology and Gastroenterology 2013; 37(2) doi: 10.1016/j.clinre.2013.02.004
69
Andreas L. Koutsoumpas, Stephen Kriese, Eirini I. Rigopoulou. Popular and unpopular infectious agents linked to primary biliary cirrhosis. Autoimmunity Highlights 2012; 3(3) doi: 10.1007/s13317-012-0039-y
70
Nikolaos C. Kyriakidis, Efstathia K. Kapsogeorgou, Athanasios G. Tzioufas. A comprehensive review of autoantibodies in primary Sjögren's syndrome: Clinical phenotypes and regulatory mechanisms. Journal of Autoimmunity 2014; 51 doi: 10.1016/j.jaut.2013.11.001
71
Sabrina Pagano, Stephan J. L. Bakker, Catherine Juillard, Stefania Vossio, Dimitri Moreau, Karim J. Brandt, François Mach, Robin P. F. Dullaart, Nicolas Vuilleumier. Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04569-7
72
Daniel S. Smyk, Dimitrios P. Bogdanos, Albert Pares, Christos Liaskos, Charalambos Billinis, Andrew K. Burroughs, Eirini I. Rigopoulou. Tuberculosis Is Not a Risk Factor for Primary Biliary Cirrhosis: A Review of the Literature. Tuberculosis Research and Treatment 2012; 2012 doi: 10.1155/2012/218183
73
Dimitrios P. Bogdanos, Daniel S. Smyk, Eirini I. Rigopoulou, Maria G. Mytilinaiou, Michael A. Heneghan, Carlo Selmi, M. Eric Gershwin. Twin studies in autoimmune disease: Genetics, gender and environment. Journal of Autoimmunity 2012; 38(2-3) doi: 10.1016/j.jaut.2011.11.003
74
Mauro Podda, Carlo Selmi, Ana Lleo, Luca Moroni, Pietro Invernizzi. The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. Journal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.06.015
75
Vasiliki-Kalliopi Bournia, Panayiotis G. Vlachoyiannopoulos. Subgroups of Sjögren syndrome patients according to serological profiles. Journal of Autoimmunity 2012; 39(1-2) doi: 10.1016/j.jaut.2012.03.001
76
George F. Mells, Arthur Kaser, Tom H. Karlsen. Novel insights into autoimmune liver diseases provided by genome-wide association studies. Journal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.07.004
77
Daijun Xiang, Qing Xia, Dexi Chen, Xia Feng, Yan Zhao, Yan Liu, Huiyu Liao, Yanmin Liu, Ning Li, Huiping Yan. Detection of D‐3‐phosphoglycerate dehydrogenase autoantibodies in patients with autoimmune hepatitis: Clinical significance evaluation. Hepatology Research 2011; 41(9) doi: 10.1111/j.1872-034X.2011.00839.x
78
Zhen Cheng, Yuehua Wang, Bin Li. Dietary Polyphenols Alleviate Autoimmune Liver Disease by Mediating the Intestinal Microenvironment: Challenges and Hopes. Journal of Agricultural and Food Chemistry 2022; 70(35) doi: 10.1021/acs.jafc.2c02654
79
Dimitrios P. Bogdanos, Lars Komorowski. Disease-specific autoantibodies in primary biliary cirrhosis. Clinica Chimica Acta 2011; 412(7-8) doi: 10.1016/j.cca.2010.12.019
80
R. Liberal, G. Mieli-Vergani, D. Vergani. Autoimmune hepatitis: From mechanisms to therapy. Revista Clínica Española (English Edition) 2016; 216(7) doi: 10.1016/j.rceng.2016.04.004
81
Moushumi Lodh, Debkant Pradhan, Ashok Parida. Autoimmune Hepatitis with Anti Centromere Antibodies. Case Reports in Immunology 2013; 2013 doi: 10.1155/2013/742080
82
Suvradeep Mitra, Ranjana Walker Minz. Autoantibodies in Autoimmune Liver Diseases—Methods of Detection and Interpretation. International Journal of Surgical Pathology 2016; 24(7) doi: 10.1177/1066896916657643
83
Vaibhav Mehendiratta, Pradnya Mitroo, Alessandro Bombonati, Victor J. Navarro, Simona Rossi, Raphael Rubin, Steven K. Herrine. Serologic Markers Do Not Predict Histologic Severity or Response to Treatment in Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 2009; 7(1) doi: 10.1016/j.cgh.2008.08.043
84
Diego Vergani, Giorgina Mieli-Vergani. Cutting Edge Issues in Autoimmune Hepatitis. Clinical Reviews in Allergy & Immunology 2012; 42(3) doi: 10.1007/s12016-010-8236-9
85
Carlo Selmi, Cecilia B. Chighizola, Angela Ceribelli, Maria De Santis, Pier Luigi Meroni, Renqian Zhong. Liver Immunology. 2014;  doi: 10.1007/978-3-319-02096-9_3
86
George F Mells, Gideon M Hirschfield. Encyclopedia of Life Sciences. 2013;  doi: 10.1002/9780470015902.a0024406
87
Ian R. Mackay. Systemic Lupus Erythematosus. 2011;  doi: 10.1016/B978-0-12-374994-9.10046-4
88
C. Johanet, E. Ballot. Autoanticorps en hépatologie. EMC - Hépatologie 2010; 25(2) doi: 10.1016/S1155-1976(10)50168-2
89
Gary L. Norman, Nicola Bizzaro, Danilo Villalta, Diego Vergani, Giorgina Mieli-Vergani, Gideon M. Hirschfield, Michael Mahler. Precision Medicine and Artificial Intelligence. 2021;  doi: 10.1016/B978-0-12-820239-5.00012-7
90
Yu. G. Sandler, E. V. Vinnitskaya, K. L. Raikhelson, K. V. Ivashkin, S. N. Batskikh, E. N. Aleksandrova, D. T. Abdurakhmanov, D. I. Abdulganieva, I. G. Bakulin, A. O. Bueverov, S. L. Vorobyev, O. A. Gerasimova, A. I. Dolgushina, M. S. Zhuravleva, L. Yu. Ilchenko, V. E. Karev, N. V. Korochanskaya, I. L. Kliaritskaia, N. S. Karnaukhov, S. V. Lapin, M. A. Livzan, M. V. Maevskaya, N. V. Marchenko, T. P. Nekrasova, I. G. Nikitin, A. A. Novikov, R. G. Saifutdinov, E. V. Skazyvaeva, V. E. Syutkin, M. K. Prashnova, T. Yu. Khaymenova, S. G. Khomerik. Diagnosis and Treatment of Patients with Autoimmune Hepatitis (Experts’ Agreement). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 34(6) doi: 10.22416/1382-4376-2024-34-6-100-119
91
Antonio Di Sabatino, Federico Biagi, Marco Lenzi, Luca Frulloni, Marco Vincenzo Lenti, Paolo Giuffrida, Gino Roberto Corazza. Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. Digestive and Liver Disease 2017; 49(9) doi: 10.1016/j.dld.2017.06.010
92
Ingvar Bjarnason, Bu Hayee, Polychronis Pavlidis, Charlotte Kvasnovsky, Astrid Scalori, Guy Sisson, Annika Charlesworth, Hizbullah Shaikh, Einar Bjornsson, Michael A. Heneghan. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis. EBioMedicine 2015; 2(10) doi: 10.1016/j.ebiom.2015.08.041
93
Hanna Wichary, Teresa Gasińska. Methylprednisolone and Hepatotoxicity in Graves' Ophthalmopathy. Thyroid 2012; 22(1) doi: 10.1089/thy.2010.0158
94
Daniel S. Smyk, Timoklia Orfanidou, Pietro Invernizzi, Dimitrios P. Bogdanos, Marco Lenzi. Vitamin D in autoimmune liver disease. Clinics and Research in Hepatology and Gastroenterology 2013; 37(5) doi: 10.1016/j.clinre.2013.05.016
95
Rodrigo Liberal, Charlotte R. Grant, Maria Serena Longhi, Giorgina Mieli-Vergani, Diego Vergani. Diagnostic criteria of autoimmune hepatitis. Autoimmunity Reviews 2014; 13(4-5) doi: 10.1016/j.autrev.2013.11.009
96
Daniel Smyk, Eirini I. Rigopoulou, Harold Baum, Andrew K. Burroughs, Diego Vergani, Dimitrios P. Bogdanos. Autoimmunity and Environment: Am I at risk?. Clinical Reviews in Allergy & Immunology 2012; 42(2) doi: 10.1007/s12016-011-8259-x
97
Diego Vergani, Ian R. Mackay, Giorgina Mieli-Vergani. The Autoimmune Diseases. 2014;  doi: 10.1016/B978-0-12-384929-8.00061-7
98
Aalam Sohal, Kris V Kowdley. Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores. Hepatic Medicine: Evidence and Research 2023;  doi: 10.2147/HMER.S361077
99
E. A. Boström, M. Ekstedt, S. Kechagias, C. Sjöwall, M. I. Bokarewa, S. Almer. Resistin is Associated with Breach of Tolerance and Anti‐nuclear Antibodies in Patients with Hepatobiliary Inflammation. Scandinavian Journal of Immunology 2011; 74(5) doi: 10.1111/j.1365-3083.2011.02592.x
100
Manal A Hamed, Sanaa A Ali. Non-viral factors contributing to hepatocellular carcinoma. World Journal of Hepatology 2013; 5(6): 311-322 doi: 10.4254/wjh.v5.i6.311
101
Christiane Radzimski, Christian Probst, Bianca Teegen, Kristin Rentzsch, Inga Madeleine Blöcker, Cornelia Dähnrich, Wolfgang Schlumberger, Winfried Stöcker, Dimitrios P. Bogdanos, Lars Komorowski. Development of a Recombinant Cell-Based Indirect Immunofluorescence Assay for the Determination of Autoantibodies against Soluble Liver Antigen in Autoimmune Hepatitis. Clinical and Developmental Immunology 2013; 2013 doi: 10.1155/2013/572815
102
Tingting Zeng, Jianlin Yu, Liming Tan, Yang Wu, Yongjian Tian, Qiong Wu, Xingwang Duan, Le Yu. Noninvasive indices for monitoring disease course in Chinese patients with autoimmune hepatitis. Clinica Chimica Acta 2018; 486 doi: 10.1016/j.cca.2018.07.030
103
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Liver Immunology. 2020;  doi: 10.1007/978-3-030-51709-0_26
104
Danilo Villalta, Elia Girolami, Maria Grazia Alessio, Maria Concetta Sorrentino, Marilina Tampoia, Ignazio Brusca, Massimo Daves, Brunetta Porcelli, Giuseppina Barberio, Mariaelisabetta Conte, Lisa Pantarotto, Nicola Bizzaro. Autoantibody Profiling in a Cohort of Pediatric and Adult Patients With Autoimmune Hepatitis. Journal of Clinical Laboratory Analysis 2016; 30(1) doi: 10.1002/jcla.21813
105
Elze Maria Gomes Oliveira, Maria Lucia Gomes Ferraz. Biomarcadores em Hepatologia. Revista Paulista de Reumatologia 2019; (2019 jul-set;18(3)) doi: 10.46833/reumatologiasp.2019.18.3.18-23
106
Edith Hintermann, Camilla Tondello, Sina Fuchs, Monika Bayer, Josef M. Pfeilschifter, Richard Taubert, Martin Mollenhauer, Roland P.J. Oude Elferink, Michael P. Manns, Urs Christen. Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice. Journal of Autoimmunity 2024; 146 doi: 10.1016/j.jaut.2024.103229
107
Dimitrios P. Bogdanos, Daniel S. Smyk, Pietro Invernizzi, Eirini I. Rigopoulou, Miri Blank, Lazaros Sakkas, Shideh Pouria, Yehuda Shoenfeld. Tracing environmental markers of autoimmunity: introducing the infectome. Immunologic Research 2013; 56(2-3) doi: 10.1007/s12026-013-8399-6
108
Inanc KARAKOYUN, Celal ULAŞOĞLU, Fatma Demet ARSLAN, Selin ONUR, Veli İYİLİKCİ, Banu Isbilen BASOK, Ayfer ÇOLAK. Oxidative imbalance in autoimmune liver disease: evaluation of oxidant-antioxidant status and ischemia-modified albumin. SDÜ Tıp Fakültesi Dergisi 2021; 28(1) doi: 10.17343/sdutfd.738119
109
Qifeng Song, Guozhen Liu, Shaohui Hu, Yan Zhang, Yong Tao, Yuning Han, Haipan Zeng, Wei Huang, Fang Li, Peng Chen, Jianhui Zhu, Chaojun Hu, Shulan Zhang, Yongzhe Li, Heng Zhu, Lin Wu. Novel Autoimmune Hepatitis-Specific Autoantigens Identified Using Protein Microarray Technology. Journal of Proteome Research 2010; 9(1) doi: 10.1021/pr900131e
110
Ruiling Chen, Ruqi Tang, Xiong Ma, M. Eric Gershwin. Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis. Clinics in Liver Disease 2022; 26(4) doi: 10.1016/j.cld.2022.06.003
111
Joanna Raszeja-Wyszomirska, Ewa Wunsch, Agnieszka Kempinska-Podhorodecka, Daniel S. Smyk, Dimitrios P. Bogdanos, Malgorzata Milkiewicz, Piotr Milkiewicz. TRAF1-C5Affects Quality of Life in Patients with Primary Biliary Cirrhosis. Clinical and Developmental Immunology 2013; 2013 doi: 10.1155/2013/510547
112
Zisis Tsouris, Christos Liaskos, Efthymios Dardiotis, Thomas Scheper, Vana Tsimourtou, Wolfgang Meyer, George Hadjigeorgiou, Dimitrios P. Bogdanos. A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis. Autoimmunity Highlights 2020; 11(1) doi: 10.1186/s13317-020-00130-4
113
Daniel S. Smyk, Maria G. Mytilinaiou, Tassos Grammatikopoulos, A. S. Knisely, Giorgina Mieli-Vergani, Dimitrios P. Bogdanos, Diego Vergani. Primary Biliary Cirrhosis-Specific Antimitochondrial Antibodies in Neonatal Haemochromatosis. Clinical and Developmental Immunology 2013; 2013 doi: 10.1155/2013/642643
114
Alejandro Campos-Murguia, Nicole Henjes, Stephanie Loges, Heiner Wedemeyer, Elmar Jaeckel, Richard Taubert, Bastian Engel. Evaluation of immunoserological detection of anti-liver kidney microsomal, anti-soluble liver antigen and anti-mitochondrial antibodies. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-37095-z
115
Haiying Liu, Yunfeng Liu, Luxia Wang, Dexing Xu, Bingliang Lin, Renqian Zhong, Sitang Gong, Mauro Podda, Pietro Invernizzi. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-100
116
Agata Mostkowska, Guy Rousseau, Noël J‐M Raynal. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases. The FASEB Journal 2024; 38(5) doi: 10.1096/fj.202302259RR
117
Rodrigo Liberal, Charlotte R. Grant, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 2013; 41 doi: 10.1016/j.jaut.2012.11.002
118
Guillermo Muñoz-Sánchez, Albert Pérez-Isidro, Iñaki Ortiz de Landazuri, Antonio López-Gómez, Luz Yadira Bravo-Gallego, Milagros Garcia-Ormaechea, Maria Rosa Julià, Odette Viñas, Estíbaliz Ruiz-Ortiz. Working Algorithms and Detection Methods of Autoantibodies in Autoimmune Liver Disease: A Nationwide Study. Diagnostics 2022; 12(3) doi: 10.3390/diagnostics12030697
119
Ikuko Haruta, Ken Kikuchi, Etsuko Hashimoto, Minoru Nakamura, Hiroshi Miyakawa, Katsuhiko Hirota, Noriyuki Shibata, Hidehito Kato, Yutaka Arimura, Yoichiro Kato, Takehiko Uchiyama, Hideaki Nagamune, Makio Kobayashi, Yoichiro Miyake, Keiko Shiratori, Junji Yagi. Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation. Laboratory Investigation 2010; 90(4) doi: 10.1038/labinvest.2010.40
120
Diane Giovannini, Aude Belbezier, Athan Baillet, Laurence Bouillet, Mitsuhiro Kawano, Chantal Dumestre-Perard, Giovanna Clavarino, Johan Noble, Jacques-Olivier Pers, Nathalie Sturm, Bertrand Huard. Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1111366
121
Eirini I Rigopoulou, Dimitrios P Bogdanos. Role of autoantibodies in the clinical management of primary biliary cholangitis. World Journal of Gastroenterology 2023; 29(12): 1795-1810 doi: 10.3748/wjg.v29.i12.1795
122
Daniel Smyk, Tassos Grammatikopoulos, Alexandros Daponte, Eirini I. Rigopoulou, Dimitrios P. Bogdanos. Fetomaternal alloimmunity as a cause of liver disease. Autoimmunity Highlights 2011; 2(1) doi: 10.1007/s13317-011-0019-7
123
Chiara Zingaretti, Milena Arigò, Angela Cardaci, Monica Moro, Mariacristina Crosti, Antonella Sinisi, Elisa Sugliano, Cristina Cheroni, Francesco Marabita, Renzo Nogarotto, Raoul Jean Pierre Bonnal, Paolo Marcatili, Maurizio Marconi, Annalinda Zignego, Paolo Muratori, Pietro Invernizzi, Piero Colombatto, Maurizia Brunetto, Ferruccio Bonino, Raffaele De Francesco, Jens Geginat, Massimiliano Pagani, Luigi Muratori, Sergio Abrignani, Mauro Bombaci. Identification of New Autoantigens by Protein Array Indicates a Role for IL4 Neutralization in Autoimmune Hepatitis. Molecular & Cellular Proteomics 2012; 11(12) doi: 10.1074/mcp.M112.018713
124
Andreas E Kremer, Christian Rust, Peter Eichhorn, Ulrich Beuers, Stefan Holdenrieder. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers. Expert Review of Molecular Diagnostics 2009; 9(2) doi: 10.1586/14737159.9.2.139
125
Judy Savige, Michelle Trevisin, Wendy Pollock. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease. Journal of Immunological Methods 2018; 458 doi: 10.1016/j.jim.2018.02.016
126
Gábor Nagy, Dóra Bencze, Sarolta Demeter, Krisztina Pénzes-Daku, Lilla Szabó, Beáta Tóth, Róza Földesi, Mária Papp, Péter Antal-Szalmás. Autoantibodies in the follow-up of autoimmune hepatitis. Journal of Translational Autoimmunity 2026; 12 doi: 10.1016/j.jtauto.2026.100369
127
Gideon M. Hirschfield. Liver Immunology. 2014;  doi: 10.1007/978-3-319-02096-9_9
128
Amanda PB Albuquerque, Amanda R Fernandes, Ângela LBP Duarte, Henrique de Ataide Mariz, José GCA Júnior, Luiz A Mattos, Maira Galdino da Rocha Pitta, Moacyr JBM Rêgo. ANA-HEp2 pattern evaluation in pancreatic cancer: What can the autoantibodies tell us?. Hepatobiliary & Pancreatic Diseases International 2023; 22(1) doi: 10.1016/j.hbpd.2022.02.006
129
Christos Liaskos, Eirini I. Rigopoulou, Timoklia Orfanidou, Dimitrios P. Bogdanos, Christos N. Papandreou. CUZD1 and Anti-CUZD1 Antibodies as Markers of Cancer and Inflammatory Bowel Diseases. Clinical and Developmental Immunology 2013; 2013 doi: 10.1155/2013/968041
130
Daniel S. Smyk, Eirini I. Rigopoulou, Luigi Muratori, Andrew K. Burroughs, Dimitrios P. Bogdanos. Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis. Annals of Hepatology 2012; 11(1) doi: 10.1016/S1665-2681(19)31481-4
131
CEM Rodrigues, MTC Caleiro, JF de Carvalho. Anti-liver and antiendomysial autoantibodies in primary antiphospholipid (Hughes’) syndrome. Lupus 2010; 19(13) doi: 10.1177/0961203310376638
132
Zhou Yuming, Tang Ruqi, Merrill Eric Gershwin, Ma Xiong. Autoimmune Hepatitis. Clinics in Liver Disease 2024; 28(1) doi: 10.1016/j.cld.2023.06.003
133
Dimitrios P. Bogdanos, Bin Gao, M. Eric Gershwin. Liver Immunology. Comprehensive Physiology 2013; 3(2) doi: 10.1002/j.2040-4603.2013.tb00503.x
134
Christos Liaskos, Athanasios Mavropoulos, Timoklia Orfanidou, Vassiliki Spyrou, Labrini V. Athanasiou, Charalambos Billinis. The immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitis. Autoimmunity Highlights 2012; 3(3) doi: 10.1007/s13317-012-0036-1
135
Catherine Johanet, Yannick Chantran, Eric Ballot. Auto-anticorps et pathologies hépatiques. Revue Francophone des Laboratoires 2017; 2017(490) doi: 10.1016/S1773-035X(17)30078-3
136
Albert J Czaja. Autoimmune liver disease. Current Opinion in Gastroenterology 2009; 25(3) doi: 10.1097/MOG.0b013e328324ed06
137
Agnieszka Kempinska-Podhorodecka, Zakera Shums, Michał Wasilewicz, Ewa Wunsch, Malgorzata Milkiewicz, Dimitrios P. Bogdanos, Gary L. Norman, Piotr Milkiewicz. TRAF1Gene Polymorphism Correlates with the Titre of Gp210 Antibody in Patients with Primary Biliary Cirrhosis. Clinical and Developmental Immunology 2012; 2012 doi: 10.1155/2012/487521
138
EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015; 63(4) doi: 10.1016/j.jhep.2015.06.030
139
Ian R. Mackay. Autoimmune Hepatitis: From the Clinic to the Diagnostics Laboratory. Laboratory Medicine 2011; 42(4) doi: 10.1309/LM7EUBRRUPLF9V6R
140
Yannick Chantran, Christophe Corpechot, David Haddouk, Farid Gaouar, Éric Ballot, Jean-Charles Duclos-Vallée, Olivier Chazouillères, Catherine Johanet. Anticorps anti-gp210 et anticorps anti-Sp100 dans la cirrhose biliaire primitive : une association de très mauvais pronostic. Revue Francophone des Laboratoires 2014; 2014(464) doi: 10.1016/S1773-035X(14)72594-8
141
Eirini I. Rigopoulou, Dimitrios P. Bogdanos. Is primary biliary cirrhosis rare or common? The truth lies somewhere in between. Liver International 2014; 34(7) doi: 10.1111/liv.12488
142
Pietro Invernizzi. Liver auto-immunology: The paradox of autoimmunity in a tolerogenic organ. Journal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.08.006
143
Catherine Johanet, Eric Ballot. Auto-antibodies in autoimmune hepatitis: Anti-smooth muscle antibodies (ASMA). Clinics and Research in Hepatology and Gastroenterology 2012; 36(2) doi: 10.1016/j.clinre.2011.10.012
144
Diego Vergani, Maria Serena Longhi, Dimitrios P. Bogdanos, Yun Ma, Giorgina Mieli-Vergani. Autoimmune hepatitis. Seminars in Immunopathology 2009; 31(3) doi: 10.1007/s00281-009-0170-7
145
Efstathia K. Kapsogeorgou, Athanasios G. Tzioufas. Connective Tissue Disease. Rare Diseases of the Immune System 2016;  doi: 10.1007/978-3-319-24535-5_21
146
Luigi Raganelli, Tommaso Bandini, Matilde Ilacqua, Helena Cerutti, Alessandra Cartocci, Giulia Tesi, Andrea Ianniello, Thomas Massari, Mirko Berretti, Roberto Centini, Michele Norelli, Alessandra Brogi, Giampaola Pesce, Danilo Villalta, Brunetta Porcelli. Validation of a Multiparametric, Automated, Macroarray‐Based Assay for the Detection of Autoantibodies in Autoimmune Liver Disease. Journal of Clinical Laboratory Analysis 2026;  doi: 10.1002/jcla.70213
147
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseases. Journal of Autoimmunity 2010; 34(3) doi: 10.1016/j.jaut.2009.12.002
148
Mohammed A. Khedr, Tahany A. Salem, Ghada M. Boghdadi, Ahmed S. Elharoun, Allia A. El-Shahaway, Hany R. Atallah, Mostafa M. Sira. Seronegative autoimmune hepatitis in children. Wiener klinische Wochenschrift 2022; 134(5-6) doi: 10.1007/s00508-021-01907-x
149
Dermot Gleeson, Michael A Heneghan. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut 2011; 60(12) doi: 10.1136/gut.2010.235259
150
Sean R. Rudnick. Diagnosis and Management of Autoimmune Hepatitis. 2020;  doi: 10.1007/978-3-030-33628-8_3
151
Christos Liaskos, George Efthymiou, Dimitrios P. Bogdanos. Liver Diseases. 2020;  doi: 10.1007/978-3-030-24432-3_13
152
Karsten Conrad, Nadja Röber, Luis E. C. Andrade, Michael Mahler. The Clinical Relevance of Anti-DFS70 Autoantibodies. Clinical Reviews in Allergy & Immunology 2017; 52(2) doi: 10.1007/s12016-016-8564-5
153
Daniel S. Smyk, Eirini I. Rigopoulou, Albert Pares, Charalambos Billinis, Andrew K. Burroughs, Luigi Muratori, Pietro Invernizzi, Dimitrios P. Bogdanos. Sex Differences Associated with Primary Biliary Cirrhosis. Clinical and Developmental Immunology 2012; 2012 doi: 10.1155/2012/610504
154
Wojciech Jańczyk, Joanna B. Bierła, Ilona Trojanowska, Aldona Wierzbicka-Rucińska, Bożena Cukrowska, Piotr Socha. Prevalence and Significance of Autoantibody Seropositivity in Children with Wilson’s Disease. Diagnostics 2023; 13(4) doi: 10.3390/diagnostics13040768
155
Dimitrios P. Bogdanos. Autoimmune Hepatitis. 2012;  doi: 10.1007/978-1-60761-569-9_4
156
Pietro Invernizzi, Xavier Bossuyt, Dimitrios P. Bogdanos. Serum Autoantibodies: From Identification to Clinical Relevance. Clinical and Developmental Immunology 2013; 2013 doi: 10.1155/2013/382069
157
Haiying Liu, Gary L. Norman, Zakera Shums, Howard J. Worman, Edward L. Krawitt, Nicola Bizzaro, Diego Vergani, Dimitrios P. Bogdanos, George N. Dalekos, Piotr Milkiewicz, Albert J. Czaja, E. Jenny Heathcote, Gideon M. Hirschfield, Eng M. Tan, Kiyomitsu Miyachi, Monica Bignotto, Pier Maria Battezzati, Ana Lleo, Patrick S. Leung, Mauro Podda, M. Eric Gershwin, Pietro Invernizzi. PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. Journal of Autoimmunity 2010; 35(4) doi: 10.1016/j.jaut.2010.09.005
158
Juan Francisco Delgado de la Poza, M. Pilar Palomino Díaz, Carmen Rodríguez Hernández. Protocolos de diagnóstico inmunológico en enfermedades autoinmunes. 2014;  doi: 10.1016/B978-84-9022-602-5.00011-2
159
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. Clinical Reviews in Allergy & Immunology 2021; 63(2) doi: 10.1007/s12016-021-08888-9
160
A. Soares, R. Cunha, F. Rodrigues, H. Ribeiro. Smooth muscle autoantibodies with F-actin specificity. Autoimmunity Reviews 2009; 8(8) doi: 10.1016/j.autrev.2009.02.023
161
Malgorzata Milkiewicz, Llorenç Caballería, Daniel S. Smyk, Piotr Milkiewicz. Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies. Autoimmunity Highlights 2012; 3(3) doi: 10.1007/s13317-012-0038-z
162
Maria G. Mytilinaiou, Wolfgang Meyer, Thomas Scheper, Eirini I. Rigopoulou, Christian Probst, Andreas L. Koutsoumpas, Daniel Abeles, Andrew K. Burroughs, Lars Komorowski, Diego Vergani, Dimitrios P. Bogdanos. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. Clinica Chimica Acta 2012; 413(15-16) doi: 10.1016/j.cca.2012.03.020
163
Lingyan Liu, Junying Cao, Zhengrong Zhong, Zhuying Guo, Yunfei Jiang, Yupan Bai, Jie Xu. Noninvasive indicators predict advanced liver fibrosis in autoimmune hepatitis patients. Journal of Clinical Laboratory Analysis 2019; 33(7) doi: 10.1002/jcla.22922
164
Sina Fuchs, Monika Bayer, Richard Taubert, Michael P. Manns, Josef M. Pfeilschifter, Urs Christen, Edith Hintermann. Effects of adenovirus‐induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model. Liver International 2019; 39(12) doi: 10.1111/liv.14183
165
Hyun Jin Cha, Jimin Hwang, Lucy Eunju Lee, Younhee Park, Jason Jungsik Song, Gianfranco D. Alpini. The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease. PLOS ONE 2021; 16(1) doi: 10.1371/journal.pone.0244950
166
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. Journal of Autoimmunity 2018; 95 doi: 10.1016/j.jaut.2018.10.004
167
Athanasios Mavropoulos, Timoklia Orfanidou, Christos Liaskos, Daniel S. Smyk, Charalambos Billinis, Miri Blank, Eirini I. Rigopoulou, Dimitrios P. Bogdanos. p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: Lessons to learn from ANCA vasculitis and pemphigus vulgaris. Autoimmunity Reviews 2013; 12(5) doi: 10.1016/j.autrev.2012.10.019
168
Simona Marzorati, Pietro Invernizzi, Ana Lleo. Making Sense of Autoantibodies in Cholestatic Liver Diseases. Clinics in Liver Disease 2016; 20(1) doi: 10.1016/j.cld.2015.08.003
169
Pietro Invernizzi, Maria Grazia Alessio, Daniel S Smyk, Ana Lleo, Aurelio Sonzogni, Luca Fabris, Manila Candusso, Dimitrios P Bogdanos, Raffaele Iorio, Giuliano Torre. Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-92
170
Daniel S Smyk, Eirini I Rigopoulou, Ana Lleo, Robin D Abeles, Athanasios Mavropoulos, Charalambos Billinis, Pietro Invernizzi, Dimitrios P Bogdanos. Immunopathogenesis of primary biliary cirrhosis: an old wives' tale. Immunity & Ageing 2011; 8(1) doi: 10.1186/1742-4933-8-12
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.